Clinical development of products for specific immunotherapy for the treatment of allergic diseases - Scientific guideline

This document provides guidance for the development of studies of products for specific immunotherapy to enhance the assessment and comparison of results of such studies.

Keywords: Allergic disease, specific immunotherapy, allergic rhinoconjunctivitis

Current effective version

Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases

AdoptedLegal effective date: 01/06/2009Reference Number: CHMP/EWP/18504/2006

Document history - First version (current)

Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases

AdoptedLegal effective date: 01/06/2009Reference Number: CHMP/EWP/18504/2006

Draft guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases

Draft: consultation closedReference Number: CHMP/EWP/18504/2006

Concept paper on the preparation of a guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases

Reference Number: EMEA/CHMP/EWP/18504/2006